![](/images/graphics-bg.png)
Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Joint Authors
González-Redondo, R.
Guridi, J.
Obeso, J. A.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-15, 15 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-10-17
Country of Publication
Egypt
No. of Pages
15
Main Subjects
Abstract EN
Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal movement control.
In patients with Parkinson’s disease, the chronic levodopa treatment induces dyskinetic movements known as levodopa-induced dyskinesias (LID).
This paper analyzed the pathophysiology, clinical manifestations, pharmacological treatments, and surgical procedures to treat hyperkinetic disorders.
Surgery is currently the only treatment available for Parkinson’s disease that may improve both parkinsonian motor syndrome and LID.
However, this paper shows the different mechanisms involved are not well understood.
American Psychological Association (APA)
Guridi, J.& González-Redondo, R.& Obeso, J. A.. 2012. Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Parkinson’s Disease،Vol. 2012, no. 2012, pp.1-15.
https://search.emarefa.net/detail/BIM-510182
Modern Language Association (MLA)
Guridi, J.…[et al.]. Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Parkinson’s Disease No. 2012 (2012), pp.1-15.
https://search.emarefa.net/detail/BIM-510182
American Medical Association (AMA)
Guridi, J.& González-Redondo, R.& Obeso, J. A.. Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Parkinson’s Disease. 2012. Vol. 2012, no. 2012, pp.1-15.
https://search.emarefa.net/detail/BIM-510182
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-510182